Fuso Pharmaceutical Industries (TSE:4538) EPS (Basic): 円97.40 (TTM As of Mar. 2026)


TSE:4538 Fuso Pharmaceutical Industries Ltd TSE:4538
47 GF Score
Price 円2,066.00
GF Value 円2,539.87
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Fuso Pharmaceutical Industries EPS (Basic)?

Fuso Pharmaceutical Industries TSE:4538 +0.54% 47 EPS (Basic) is 円97.40 as of Mar. 2026. GuruFocus rates TSE:4538 with a GF Score™ of 47/100 and a GF Value™ of 円2,539.87 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Fuso Pharmaceutical Industries's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was 円0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was 円97.40.

Fuso Pharmaceutical Industries's EPS (Diluted) for the three months ended in Mar. 2026 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円97.40.

Fuso Pharmaceutical Industries's EPS without NRI for the three months ended in Mar. 2026 was 円0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 96.96.

During the past 12 months, Fuso Pharmaceutical Industries's average EPS without NRIGrowth Rate was 6.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 30.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 25.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 42.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Fuso Pharmaceutical Industries's highest 3-Year average EPS without NRI Growth Rate was 414.70% per year. The lowest was -86.50% per year. And the median was 2.45% per year.

Fuso Pharmaceutical Industries  (TSE:4538) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fuso Pharmaceutical Industries EPS (Basic) Related Terms

Fuso Pharmaceutical Industries EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Fuso Pharmaceutical Industries's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuso Pharmaceutical Industries EPS (Basic) Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 169.09 183.07 159.98 -384.95 235.63

Fuso Pharmaceutical Industries Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.70 0.00 54.14 43.26 0.00
TSE:4538
47GF Score
Fuso Pharmaceutical Industries Ltd TSE:4538
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuso Pharmaceutical Industries EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Fuso Pharmaceutical Industries's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2011-0)/8.539
=235.51

Fuso Pharmaceutical Industries's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0-0)/8.539
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円97.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円97.40 mean?
Fuso Pharmaceutical Industries (TSE:4538) has a EPS (Basic) of 円97.40 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fuso Pharmaceutical Industries and its competitors.
Is Fuso Pharmaceutical Industries' EPS (Basic) too high?
Fuso Pharmaceutical Industries' current EPS (Basic) is 円97.40. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' EPS (Basic) compare to ZTS?
Fuso Pharmaceutical Industries' EPS (Basic) of 円97.40 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fuso Pharmaceutical Industries and its competitors. Fuso Pharmaceutical Industries's current EPS (Basic) is 円97.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,539.87, compared to a current price of 円2,066.00 — trading 18.7% below its estimated fair value. The current EPS (Basic) is 円97.40. Fuso Pharmaceutical Industries' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current EPS (Basic) is 円97.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued. The current stock price of 円2,066.00 is trading 18.7% below its estimated GF Value™ of 円2,539.87. GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.

Key valuation signals for TSE:4538:

  • EPS (Basic): 円97.40
  • GF Value™: 円2,539.87 vs. price of 円2,066.00 (18.7% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuso Pharmaceutical Industries Business Description

Address No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
47GF Score

Get the complete analysis for TSE:4538

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,066.00
Price
円2,539.87
GF Value